TRICON

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: TRICON
Generic name: TRICON
Manufacturer: Nnodum Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: d891ab47-4a05-4b5b-b372-7ddf91699c29
SPL ID: 39029624-9348-4703-ba23-1dc64084909e
Version: 10
Effective date: 2025-12-29
Source export date: 2026-10-12
Source partition: 10
Source file: https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/befa34274042a52f589b22fe2add0b1c6f0a385c96447c28303de164bb144af5/drug-label-0010-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:29:03

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		TRICON	openfda.brand_name
generic name		TRICON	openfda.generic_name
manufacturer name		Nnodum Pharmaceuticals	openfda.manufacturer_name
ndc	package	63044-635-10	openfda.package_ndc
ndc	product	63044-635	openfda.product_ndc
ndc11	package	63044063510	derived:openfda.package_ndc
rxcui		999799	openfda.rxcui
spl id		39029624-9348-4703-ba23-1dc64084909e	id
spl set id		d891ab47-4a05-4b5b-b372-7ddf91699c29	set_id
unii		R5L488RY0Q	openfda.unii
unii		935E97BOY8	openfda.unii
unii		PQ6CK8PD0R	openfda.unii
unii		P6YC3EG204	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS Rarely, iron in therapeutic doses produces gastrointestinal reactions, such as diarrhea or constipation. Reducing the dose and administering it with meals will minimize these effects in the iron-sensitive patient. In extremely rare instances, skin rash suggesting allergy has been noted following the oral administration of liver-stomach material. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.